Literature DB >> 26234545

Noninvasive Assessment of Skeletal Microstructure and Estimated Bone Strength in Hypoparathyroidism.

Natalie E Cusano1, Kyle K Nishiyama1, Chengchen Zhang1, Mishaela R Rubin1, Stephanie Boutroy2, Donald J McMahon1, X Edward Guo3, John P Bilezikian1.   

Abstract

In hypoparathyroidism, areal bone mineral density (BMD) by dual-energy X-ray absorptiometry (DXA) is above average, and skeletal indices by bone biopsy are abnormal. We used high-resolution peripheral quantitative computed tomography (HRpQCT) and finite element analyses (FEA) to further investigate skeletal microstructure and estimated bone strength. We studied 60 hypoparathyroid subjects on conventional therapy using DXA, HRpQCT, and FEA of the distal radius and tibia compared with normative controls from the Canadian Multicentre Osteoporosis Study. In hypoparathyroid women and men, areal BMD was above average at the lumbar spine and hip sites by DXA; radial BMD was also above average in hypoparathyroid women. Using HRpQCT, cortical volumetric BMD was increased in the hypoparathyroid cohort compared with controls at both the radius and tibia. Cortical porosity was reduced at both sites in pre- and postmenopausal women and at the tibia in young men with a downward trend at the radius in men. At the tibia, trabecular number was increased in premenopausal women and men and trabecular thickness was lower in women. Ultimate stress and failure load at both sites for the hypoparathyroid subjects were similar to controls. Using a linear regression model, at both radius and tibia, each increment in age decreased ultimate stress and failure load, whereas each increment in duration of hypoparathyroidism increased these same indices. These results provide additional evidence for the critical role of parathyroid hormone in regulating skeletal microstructure. Longer disease duration may mitigate the adverse effects of age on estimated bone strength in hypoparathyroidism.
© 2015 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE MICROARCHITECTURE; HIGH-RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY (HRpQCT); HYPOPARATHYROIDISM

Mesh:

Year:  2015        PMID: 26234545      PMCID: PMC4832602          DOI: 10.1002/jbmr.2609

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  41 in total

1.  Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.

Authors:  John P Bilezikian; Aliya Khan; John T Potts; Maria Luisa Brandi; Bart L Clarke; Dolores Shoback; Harald Jüppner; Pierre D'Amour; John Fox; Lars Rejnmark; Leif Mosekilde; Mishaela R Rubin; David Dempster; Rachel Gafni; Michael T Collins; Jim Sliney; James Sanders
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

2.  Age-related patterns of trabecular and cortical bone loss differ between sexes and skeletal sites: a population-based HR-pQCT study.

Authors:  Heather M Macdonald; Kyle K Nishiyama; Jian Kang; David A Hanley; Steven K Boyd
Journal:  J Bone Miner Res       Date:  2011-01       Impact factor: 6.741

3.  In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography.

Authors:  Stephanie Boutroy; Mary L Bouxsein; Francoise Munoz; Pierre D Delmas
Journal:  J Clin Endocrinol Metab       Date:  2005-09-27       Impact factor: 5.958

4.  A new method to determine trabecular bone elastic properties and loading using micromechanical finite-element models.

Authors:  B van Rietbergen; H Weinans; R Huiskes; A Odgaard
Journal:  J Biomech       Date:  1995-01       Impact factor: 2.712

5.  Age-related changes in the tensile properties of cortical bone. The relative importance of changes in porosity, mineralization, and microstructure.

Authors:  R W McCalden; J A McGeough; M B Barker; C M Court-Brown
Journal:  J Bone Joint Surg Am       Date:  1993-08       Impact factor: 5.284

6.  Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure.

Authors:  Rachel I Gafni; Jaime S Brahim; Panagiota Andreopoulou; Nisan Bhattacharyya; Marilyn H Kelly; Beth A Brillante; James C Reynolds; Hua Zhou; David W Dempster; Michael T Collins
Journal:  J Bone Miner Res       Date:  2012-08       Impact factor: 6.741

7.  Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism.

Authors:  Edda Vignali; Giuseppe Viccica; Daniele Diacinti; Filomena Cetani; Luisella Cianferotti; Elena Ambrogini; Chiara Banti; Romano Del Fiacco; John P Bilezikian; Aldo Pinchera; Claudio Marcocci
Journal:  J Clin Endocrinol Metab       Date:  2009-04-28       Impact factor: 5.958

Review 8.  Hyperthyroidism, thyroid hormone therapy, and bone.

Authors:  D S Ross
Journal:  Thyroid       Date:  1994       Impact factor: 6.568

9.  Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis.

Authors:  Claudie Berger; David Goltzman; Lisa Langsetmo; Lawrence Joseph; Stuart Jackson; Nancy Kreiger; Alan Tenenhouse; K Shawn Davison; Robert G Josse; Jerilynn C Prior; David A Hanley
Journal:  J Bone Miner Res       Date:  2010-09       Impact factor: 6.741

10.  Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density.

Authors:  Maira L Mendonça; Francisco A Pereira; Marcello H Nogueira-Barbosa; Lucas M Monsignore; Sara R Teixeira; Plauto Ca Watanabe; Lea Mz Maciel; Francisco Ja de Paula
Journal:  BMC Endocr Disord       Date:  2013-01-03       Impact factor: 2.763

View more
  15 in total

Review 1.  Hypoparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

Review 2.  Risk of vertebral fractures in hypoparathyroidism.

Authors:  Anna Maria Formenti; Francesco Tecilazich; Raffaele Giubbini; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

Review 3.  Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology.

Authors:  Donovan Tay; Serge Cremers; John P Bilezikian
Journal:  Br J Clin Pharmacol       Date:  2017-12-06       Impact factor: 4.335

4.  The Effects of Long-term Administration of rhPTH(1-84) in Hypoparathyroidism by Bone Histomorphometry.

Authors:  Mishaela R Rubin; Hua Zhou; Natalie E Cusano; Rukshana Majeed; Beatriz Omeragic; Maximo Gomez; Thomas L Nickolas; David W Dempster; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2018-08-16       Impact factor: 6.741

Review 5.  Skeletal abnormalities in Hypoparathyroidism and in Primary Hyperparathyroidism.

Authors:  Barbara C Silva; John P Bilezikian
Journal:  Rev Endocr Metab Disord       Date:  2020-11-16       Impact factor: 6.514

6.  Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism.

Authors:  Cristiana Cipriani; Alice Abraham; Barbara C Silva; Natalie E Cusano; Mishaela R Rubin; Donald J McMahon; Chengchen Zhang; Didier Hans; Shonni J Silverberg; John P Bilezikian
Journal:  Endocrine       Date:  2016-10-18       Impact factor: 3.633

Review 7.  Bone imaging in hypoparathyroidism.

Authors:  B C Silva; M R Rubin; N E Cusano; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-08-30       Impact factor: 4.507

8.  Changes in Skeletal Microstructure Through Four Continuous Years of rhPTH(1-84) Therapy in Hypoparathyroidism.

Authors:  Natalie E Cusano; Mishaela R Rubin; John M Williams; Sanchita Agarwal; Gaia Tabacco; Donovan Tay; Rukshana Majeed; Beatriz Omeragic; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2020-03-26       Impact factor: 6.741

Review 9.  Review of Hypoparathyroidism.

Authors:  Ejigayehu G Abate; Bart L Clarke
Journal:  Front Endocrinol (Lausanne)       Date:  2017-01-16       Impact factor: 5.555

10.  Vertebral Fracture Assessment in Postmenopausal Women With Postsurgical Hypoparathyroidism.

Authors:  Cristiana Cipriani; Salvatore Minisola; John P Bilezikian; Davide Diacinti; Luciano Colangelo; Valentina Piazzolla; Maurizio Angelozzi; Luciano Nieddu; Jessica Pepe; Daniele Diacinti
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.